MedPath

?Effect of butyrate in ulcerative colitis

Phase 4
Conditions
lcerative Colitis.
Registration Number
IRCT20211214053401N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

New case
Mild to moderate UC
Active phase of diseases

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expression of circadian genes including (CRY2, Bmal1 and CLOCK). Timepoint: At the beginning of the study and 12 weeks later (end of the study). Method of measurement: Blood samples will be taken from patients to evaluate the expression of circadian rhythm genes. After isolation of peripheral blood mononuclear cells, the expression of circadian genes (CRY2, Bmal1 and CLOCK) will be evaluated by RT-PCR.;Calprotectin. Timepoint: At the beginning of the study and 12 weeks later (end of the study). Method of measurement: For determination of fecal calprotectin level, 20 g of fecal sample will be taken from patients in the early morning and fecal calprotectin level will be measured using special commercial kits.
Secondary Outcome Measures
NameTimeMethod
Serum level of hs-CRP. Timepoint: Beginning of study and 12 weeks later (end of study). Method of measurement: ELIZA commercial kit.;Sleep quality. Timepoint: Beginning of study and 12 weeks later (end of study). Method of measurement: PSQI questionnaire.;Depression and anxiety. Timepoint: Beginning of study and 12 weeks later (end of study). Method of measurement: HADS (Hospital anxiety depression scale) questionnaire.;Stress. Timepoint: Beginning of study and 12 weeks later (end of study). Method of measurement: general health questionnaire.;Life quality. Timepoint: Beginning of study and 12 weeks later (end of study). Method of measurement: IBDQ-9 self-management questionnaire.;AST and ALT. Timepoint: Beginning of study and 12 weeks later (end of study). Method of measurement: commercial kit.
© Copyright 2025. All Rights Reserved by MedPath